A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Part of paid clinical trials in Denver, Colorado.
- Sponsor
- Normunity AccelCo, Inc.
- Study ID
- NCT07182149
- Phase
- PHASE1
- Status
- Recruiting
Conditions
- Cervical Cancer
- ESCC
- Endometrial Cancer
- Esophageal Adenocarcinoma
- GEJ Adenocarcinoma
- Gastric Adenocarcinoma
- HNSCC
- NSCLC
- Ovarian Cancer
- Triple Negative Breast Cancer (TNBC)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- NRM-823 — DRUGNRM-823 is a bispecific T-Cell Engager
Study Details
This study is being done to find out of NRM-823 is safe and can treat participants with locally advanced or metastatic solid tumors.
Key Dates
- First listed
- Sep 19, 2025
- Start date
- Oct 30, 2025
- Status verified
- Aug 2026
- Primary completion
- May 30, 2027
- Completion
- Oct 31, 2028
Study Design
- Enrollment
- 150 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: NRM-823Administered per protocol requirements
Primary Outcome Measure
Incidence of treatment-emergent adverse events (TEAE) [ Time Frame: From enrollment until 30 days post the last dose received by a participant ]
Central Contacts
- Judy Schnyder, MBA215-593-7119
Locations (18)
Find similar trials in Denver, CO
Nationwide
Related Studies
- Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk WomenRecruiting · M.D. Anderson Cancer Center · Miami, Florida
- Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's RegistryRecruiting · Midwest Biomedical Research · Kansas City, Missouri
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric CancerPHASE2 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas